Mail

MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

0.0212

-0.0018 (-7.83%)

At close: 3:59PM EST

Stock chart is not supported by your current browser

Previous Close	0.0230
Open	0.0235
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.0210 - 0.0235
52 Week Range	0.0200 - 0.0900
Volume	6,327,831
Avg. Volume	6,608,426

Market Cap	212.664M
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	Nov 21, 2019
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

All

News

Press Releases

PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Flagship Product Real Scientific Hemp Oil™ Featured in Us Weekly
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds®' flagship cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™) was featured in popular lifestyle outlet Us Weekly.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway Named Most Popular CBD MLM in 2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list. Additionally, Kannaway® has been listed among the Top 100 MLM Companies of 2020 by Business for Home.
PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Opens Mexico City Office
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the opening of its subsidiary HempMeds® Mexico's new office in Mexico City.
PR Newswire
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech" or "AXIM") has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. ("Sapphire") as a wholly-owned subsidiary.
PR Newswire
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, received a designated International Nomenclature Cosmetic Ingredient (INCI) name for its patent-pending molecule and flagship consumer product to be sold under the trademark Atopidine™.
PR Newswire
HempMeds®, Subsidiary of Medical Marijuana, Inc., Becomes One of the First Companies to Join Recently Launched Leafly Market
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has become one of the first 21 companies to be listed on the Leafly Market, an online store with the largest selection of hemp-derived cannabidiol (CBD) products independently tested for cannabinoid potency, pesticides and heavy metals.
PR Newswire
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Showcases International Industry Leadership at European Parliament
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will be speaking in the European Parliament at a special event on "The State of Hemp in Europe," to be held on Thursday, December 12, 2019, in Brussels, Belgium.
Benzinga
Medical Marijuana Inc. Portfolio Company Kannalife Now Trading On The OTCQB
Research recently published in the Journal of Molecular Neuroscience showed that KLS-13019 was 200 times more potent, 10 times more bioavailable, 5 times safer and 1000 times more effective than CBD.
PR Newswire
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Commences Trading on OTCQB Under Ticker Symbol "KLFE"
Medical Marijuana, Inc. (the "Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, officially commenced trading on the OTC Markets under the ticker symbol "KLFE." Medical Marijuana, Inc. became Kannalife's original investor in 2013 and currently owns approximately 26.17% common equity in the company.
PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that subsidiary HempMeds® Brasil applauds ANVISA (the National Agency for Health Supervision) for unanimously approving the regulation of medical marijuana to be sold at pharmacies and drugstores nationwide. Brazil's new regulations will be published soon on the Federal Official Gazette and entered into law 90 days after that.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 Best in Biz Awards
Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award for Most Innovative Product of the Year – Consumer for its high-quality hemp-derived cannabidiol (CBD) products. Also, Kannaway® CEO Blake Schroeder received a Bronze Award for Executive of the Year – Small Companies.
Benzinga
The US Cities Most Interested In Cannabis
While cannabis has gone from a criminalized drug to a multibillion-dollar boom in recent years, very little data exists on how interest and consumer demand differ around the country, according to Michael Coleman, the vice president of sales and marketing at Medical Marijuana Inc (OTC: MJNA), told Benzinga. "We believe this study can be useful for cannabis executives and entrepreneurs who are looking to make strategic decisions about which markets to enter," he said of the company's most recent report on geographical interest on cannabis across the U.S. The following are highlights from Medical Marijuana Inc.'s report on interest in marijuana in cities nationwide.
PR Newswire
Medical Marijuana, Inc. Reports $17.7 Million in Revenue in Q3 2019 Financial Results
SAN DIEGO , Nov. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Invited to Speak on Key Panel at 2019 Marijuana Business Conference
Caroline Heinz will speak on Dec. 12 at 2:00 p.m. on a panel entitled "Beyond Borders: Looking at Latin America as the New Frontier" discussing business opportunities allowed by regulations throughout Latin America, the current status of key revenue markets, challenges in each Latin American region and how they are being addressed, and Latin American cannabis investment opportunities. "Just like the U.S., Latin America is currently experiencing monumental shifts in acceptance and new legislation," Heinz said.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Alex Grapov to Chief Sales Officer
SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted its International Vice President, Alex Grapov, to Chief Sales Officer of the Company. "Alex has been instrumental to our international sales and operational growth for the past two years and we believe that this new role is the most natural and well-deserved next step for him to take with our Company," said Kannaway® CEO Blake Schroeder.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 BIG Awards for Business
SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® was named Small Business Company of the Year in the Life Sciences, Health, Wellness, and Nutrition category by the Business Intelligence Group's 2019 BIG Awards for Business. Also, Kannaway®'s CEO Blake Schroeder was named Small Business Executive of the Year in the Life Sciences, Health, Wellness, and Nutrition category.
PR Newswire
Medical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings
SAN DIEGO , Nov. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...
PR Newswire
Medical Marijuana, Inc. Hires Tyler Whatcott as Chief Technology Officer
SAN DIEGO, Oct. 31, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has hired Tyler Whatcott as the Company's Chief Technology Officer. Mr. Whatcott will be responsible for developing and managing the company's information technology and web platforms as it develops its current business and expands around the world. "Tyler shows great promise in leading the technological operations of our Company as he has already proven his capabilities in leading several successful IT departments at well-established and recognized companies," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Speaks at HempToday™'s Latin American and Caribbean Hemp Summit
SAN DIEGO, Oct. 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde, the President of its subsidiary HempMeds® Mexico and Latin American operations, will be a keynote speaker at HempToday™'s Latin American & Caribbean Hemp Summit on Nov. 8-9 in Montevideo, Uruguay. "I am very excited to speak at this event and help people understand the current and potential upcoming legislation on cannabis in Mexico," Elizalde said. According to Grandview Research analysts, Mexico's medical cannabis market size was valued at $47.3 million in 2018.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Joins U.S. Hemp Roundtable Board of Directors
SAN DIEGO, Oct. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been selected as a member of the Board of Directors for the U.S. Hemp Roundtable. The U.S. Hemp Roundtable, formed in 2017, is a coalition of more than 50 leading hemp companies representing every link of the industry's supply chain from seed to sale. "Since forming our company, Kannaway, in association with its parent company Medical Marijuana, Inc. and its other subsidiaries, have participated in many domestic and international efforts to advocate for expanded access to hemp by hosting educational events and speaking with prominent regulatory bodies, including but not limited to the U.S. Food and Drug Administration (FDA), Mexico's Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) and Brazil's National Sanitary Surveillance Agency (ANVISA)," said Kannaway® CEO Blake Schroeder.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Hemp for Humanity Educational Event Tour Throughout Japan
SAN DIEGO , Oct. 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc . ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's ...
PR Newswire
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Hosts Panel at Lide Futuro Debate in São Paulo
SAN DIEGO, Oct. 15, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that subsidiary HempMeds® Brasil Vice President Caroline Heinz will be hosting a featured panel at the Lide Futuro Debate entitled, "Cannabusiness: National Potential and Business Segments," on Oct. 18 at the Museum of Image and Sound (MIS) in São Paulo, Brazil. According to a survey by New Frontier Data, Brazil's cannabis market could be worth around $4.4 billion by 2022, equivalent to 6.3 percent of the total revenue of the Brazilian pharmaceutical industry. If projections are correct, Brazil could become a more prominent leader in the Latin American cannabis market, surpassing the cannabis sales revenue of both Mexico and Chile.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division
SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a new website and back office available in Japanese catered to servicing the expansion into Japan and Asia. Kannaway®'s new Japanese language website is designed to fit the specific needs of Japanese consumers and business owners. The site will feature the latest news, announcements and promotional offers from Kannaway® in a streamlined and easy-to-navigate design.
PR Newswire
Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards
SAN DIEGO, Oct. 8, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has earned two prestigious Golden Bridge Awards® -- including a Silver Award for Company of the Year in the Healthcare Products and Services category and the Company's CEO Blake Schroeder earned a Gold Award for International Executive of the Year in the Healthcare Products and Services category.